Skip to content

Supplier News

Clavis Insight acquired by Ascential

Clavis Insight acquired by Ascential

Clavis Insight, an e-commerce specialist serving product manufacturers, is being acquired by Ascential plc, an international, business-to-business information company. Financial terms of the agreement weren’t disclosed.

Lannett names Timothy Crew as CEO

Lannett names Timothy Crew as CEO

Timothy Crew, former chief executive officer of Cipla North America, is joining Lannett Co. as CEO. Plans call for Crew to take the CEO reins at effective Jan. 2, Lannett said. He also is slated to be appointed as a board director after the company’s 2018 annual shareholders meeting.

Allergan COO to become Amneal CEO

Allergan COO to become Amneal CEO

Merger partners Amneal Pharmaceuticals LLC and Impax Laboratories Inc. have tabbed Robert Stewart, executive vice president and chief operating officer of Allergan plc, to lead the combined company. Plans call for Stewart to join Amneal as president effective Jan. 25.

Bausch+Lomb releases Vyzulta

Bausch+Lomb releases Vyzulta

Bausch+Lomb has begun rolling out Vyzulta (latanoprostene bunod ophthalmic solution 0.024%) to U.S. pharmaceutical distributors. The Valeant Pharmaceuticals International subsidiary said Vyzulta is slated to become available to patients at pharmacies across the United States in the next few days.